RE: RNS - Tim McCarthy, CEO and Chairman, said: "ImmuPharma is entering a pivotal phase, focused on securing a commercial partnership for P14027 May 2026 08:37
Draft - what would you call him ??
Genuine question.
I would say he’s very talented in fantasy narrative, and I’m still here.
We all have opinions, it’s just that others don’t like or agree with those opinions and shake a bit of salt on comments, along with a good dousing of vinegar !!
Read between the lines.
The Revd.